Accessibility Menu
 
Intelligent Bio Solutions logo

Intelligent Bio Solutions

(NASDAQ) INBS

Current Price$4.01
Market Cap$8.02M
Since IPO (2020)-100%
5 Year-100%
1 Year-68%
1 Month+44%

Intelligent Bio Solutions Financials at a Glance

Market Cap

$8.02M

Revenue (TTM)

$3.91M

Net Income (TTM)

$11.61M

EPS (TTM)

$-12.32

P/E Ratio

-0.33

Dividend

$0.00

Beta (Volatility)

1.00 (Low)

Price

$4.01

Volume

190,229.793

Open

$4.39

Previous Close

$4.01

Daily Range

$3.88 - $4.57

52-Week Range

$2.27 - $24.90

INBS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Intelligent Bio Solutions

Industry

Healthcare Equipment and Supplies

Employees

55

CEO

Harry Simeonidis

Website

ibs.inc

Headquarters

New York City, NY 10019, US

INBS Financials

Key Financial Metrics (TTM)

Gross Margin

32%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

-165%

Return on Capital

-1%

Return on Assets

-78%

Earnings Yield

-3.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.02M

Shares Outstanding

2.00M

Volume

190.23K

Avg. Volume

132.79K

Financials (TTM)

Gross Profit

$1.25M

Operating Income

$10.64M

EBITDA

$9.45M

Operating Cash Flow

$9.68M

Capital Expenditure

$231.84K

Free Cash Flow

$9.91M

Cash & ST Invst.

$1.02M

Total Debt

$281.81K

Intelligent Bio Solutions Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$1.06M

+45.5%

Gross Profit

$244.99K

+522.0%

Gross Margin

23.09%

N/A

Market Cap

$8.02M

N/A

Market Cap/Employee

$160.49K

N/A

Employees

50

N/A

Net Income

$2.86M

-12.5%

EBITDA

$2.82M

-16.2%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$5.01M

+118.4%

Accounts Receivable

$878.36K

-14.8%

Inventory

$597.47K

-12.6%

Long Term Debt

$1.46M

+39308.2%

Short Term Debt

$388.75K

-23.4%

Return on Assets

-78.13%

N/A

Return on Invested Capital

-1.15%

N/A

Free Cash Flow

$4.47M

-61.3%

Operating Cash Flow

$4.48M

-62.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCLIBrainstorm Cell Therapeutics Inc.
$0.69-0.57%
CHEKCheck-Cap Ltd.
$1.68-11.11%
HSCSHeartSciences Inc.
$1.81-5.24%
BNGOBionano Genomics, Inc.
$1.15-3.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$10.62-0.05%
FFord Motor Company
$13.40-0.07%
POETPoet Technologies
$15.97-0.22%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.06-0.10%

Questions About INBS

What is the current price of Intelligent Bio Solutions?

Intelligent Bio Solutions is trading at $4.01 per share.

What is the 52-week range for Intelligent Bio Solutions?

Over the past 52 weeks, Intelligent Bio Solutions has traded between $2.27 and $24.90.

How much debt does Intelligent Bio Solutions have?

As of the most recent reporting period, Intelligent Bio Solutions reported total debt of $1.85M.

How much cash does Intelligent Bio Solutions have on hand?

Intelligent Bio Solutions reported $6.86M in cash and cash equivalents in its most recent financial results.

What is Intelligent Bio Solutions’s dividend yield?

Intelligent Bio Solutions does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.